Exposure to IGF-1, but not GH, induced trained immunity ex vivo and in vivo [157, 158], which is likely to account for the augmented ex vivo stimulated cytokine production from monocytes obtained from acromegaly patients, but also in cells obtained from healthy volunteers that are trained with IGF-1 ex vivo. This evidence concerns the gene GH1 and acromegaly.